How healthcare and pharma tech breakthroughs are helping us fight Covid-19

AI, telemedicine and medical devices

Aanand Venkatramanan of Legal & General Investment Management

Aanand Venkatramanan of Legal & General Investment Management

We have come a long way in how we respond to pandemics since the widespread outbreak of Spanish flu that is estimated to have infected 500 million and killed up to 50 million people just over a century ago.

Significant breakthroughs have been achieved in healthcare technology and pharmaceutical industry over the recent decades, and vast strides have been made in epidemic control and prevention. Yet, as governments and institutions work to prevent the further spread of what is now known as Covid-19 on one end, scientists and researchers in healthcare companies and universities are working hard to find a cure on the other. Since the outbreak of Covid-19, there has been an exponential rise in the research on coronavirus with over 1,500 papers and articles related to coronavirus published ac...

To continue reading this article...

Join Investment Week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on ETFs

JPMorgan Climate Change Solutions UCITS ETF (T3MP) invests in companies developing and scaling climate solutions.

JP Morgan AM launches UK active ETFs

First active UK equities UCITS ETF to market

clock 21 June 2022 • 2 min read
BlackRock has launched the index fund with circa €50m seed.

BlackRock launches Paris-aligned fixed income ETF

$1bn AuM in sustainable strategies

clock 14 June 2022 • 1 min read
The ETF will invest in large and mid-cap Chinese equity securities.

Franklin Templeton launches MSCI China Paris-Aligned ETF

SFDR Article 9

Melanie Boulton
clock 14 June 2022 • 1 min read